+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Spain

  • ID: 2585935
  • Report
  • Region: Spain
  • 130 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Spain

Summary

The industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Spain". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Spain. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Spain. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by a team of industry experts.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Spain, and includes -
  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Sanofi, GSK, Almirall, Roche and Boehringer Ingelheim) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Roche Diagnostic, Essilor, Zimmer Biomet and Grifols)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Spain
  • Porter’s five forces analysis for pharmaceutical and medical devices market of Spain
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities and challenges to growth in the Spanish healthcare market.
Reasons to buy

This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving the Spanish healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in the Spanish healthcare market.
Note: Product cover images may vary from those shown
2 of 3
  • Executive Summary
  • Overview of Pharmaceutical Market
  • Overview of Medical Device Market
  • Deals Analysis
  • Porter’s Five Forces Model
  • Market Access
  • Country Healthcare Landscape
  • Opportunities and Challenges
  • Appendix

List of Tables
Table 1: Major Self-Medication Product Groups, Revenue ($M), Spain, 2017
Table 2: Top Five Therapeutic Areas by Sales Through Retail Pharmacies ($B), Spain, 2017
Table 3: Diabetes Care Devices Market, Spain, Revenue ($M) and Market Share (%) of Major Companies, 2015
Table 4: IVD Devices Market, Spain, Revenue ($M) and Market Share (%) of Major Companies, 2018
Table 5: Ophthalmic Devices Market, Spain, Revenue ($M) and Market Share (%) of Major Companies, 2015
Table 6: Orthopedic Devices Market, Spain, Revenue ($M) and Market Share (%) of Major Companies, 2018
Table 7: Hospital Supplies Market, Spain, Revenue ($M) and Market Share (%) of Major Companies, 2017
Table 8: Patent Fees, Spain, 2019
Table 9: Trademark Fees, Spain, 2019
Table 10: Clinical Trial Fees, Spain, 2019
Table 11: Packaging information, Spain, 2017
Table 12: Trade Fairs, Spain, 2019

List of Figures
Figure 1: Pharmaceutical Market, Spain, Revenue ($B), 2010-2017
Figure 2: Medical Device Market, Spain, Revenue ($B), 2015-2020
Figure 3: Country Profile, Spain, 2018
Figure 4: Pharmaceutical Market, Spain, Revenue ($B), 2010-2017
Figure 5: Pharmaceutical Market, Spain, Revenue Forecast ($B), 2018-2022
Figure 6: Pharmaceutical Exports ($B), Spain, 2010-2017
Figure 7: Top Export Partners, Spain, 2017
Figure 8: Pharmaceutical Imports ($B), Spain, 2010-2017
Figure 9: Top Import Partners, Spain, 2017
Figure 10: Generic Drugs Market (% share), Spain, 2008-2016
Figure 11: Recent Developments in the Spanish Biosimilar Industry, Spain, 2018-2019
Figure 12: Pharmaceutical OTC Market, Spain, Revenue ($B), 2010-2017
Figure 13: Major Self-Medication Product Groups, Revenue ($M), Spain, 2017
Figure 14: Top Five Therapeutic Areas by Sales Through Retail Pharmacies ($B), Spain, 2017
Figure 15: Pharmaceutical Market, Major Players, 2017
Figure 16: Medical Device Market, Spain, Revenue ($B), 2015-2020
Figure 17: Medical Device Market, Spain, Revenue Forecast ($B), 2021-2025
Figure 18: Medical Device Market, Spain, Revenue by Segment ($B), 2018
Figure 19: Diabetes Care Devices Market, Spain, Revenue ($B), 2015-2022
Figure 20: Diabetes Care Devices Market, Spain, Market Share of Major Players (%), 2015
Figure 21: In Vitro Diagnostics Devices Market, Spain, Revenue ($B), 2015-2022
Figure 22: In Vitro Diagnostics Devices Market, Spain, Market Share of Major Companies (%), 2016
Figure 23: Ophthalmic Devices Market, Spain, Revenue ($B), 2015-2022
Figure 24: Ophthalmic Devices Market, Spain, Market Share of Major Players (%), 2017
Figure 25: Orthopedic Devices Market, Spain, Revenue ($B), 2015-2022
Figure 26: Orthopedic Devices Market, Spain, Market Share of Major Players (%), 2016
Figure 27: Hospital Supplies Market, Spain, Revenue ($B), 2015-2022
Figure 28: Hospital Supplies Market, Spain, Market Share of Major Players (%), 2017
Figure 29: Diagnostic Market, Spain, Revenue ($B), 2015-2020
Figure 30: Diagnostic Market, Spain, Revenue ($B), 2021-2025
Figure 31: Medical Device Market, Spain, Revenue ($B) of Major Companies, 2017
Figure 32: Deal Value and Deal Count, Pharmaceutical Market, Spain, 2018-2019
Figure 33: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Spain, 2018-2019
Figure 34: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Spain, 2018-2019
Figure 35: Top Five Therapy Areas by Deal Value, Pharmaceutical Market, Spain, 2018-2019
Figure 36: Top Five Therapy Areas by Deal Number, Pharmaceutical Market, Spain, 2018-2019
Figure 37: M&A Deals by Therapy Area, Pharmaceutical Market, Spain, 2018-2019 (by value and by number)
Figure 38: Venture Financing Deals by Therapy Area, Pharmaceutical Market Spain, 2018-2019(by value and by number)
Figure 39: Medical Device Market Deals (by deal value, $M), Spain, 2018
Figure 40: Private Equity Deals by Therapy Area, Pharmaceutical Market, Spain, 2018-2019(by value and by number)
Figure 41: Medical Device Market Deals (by deal count), Spain, 2018-2019
Figure 42: Medical Device Market Deals Share (by deal count), Spain, 2018-2019
Figure 43: Medical Device Market Deals Share (by deal value), Spain, 2018-2019
Figure 44: Medical Device Market Deals Share (by deal value), Spain, 2018-2019
Figure 45: Medical Device Market Deals, Spain, Top Therapy Area by Deal Value, 2018-2019
Figure 46: Medical Device Market Deals, Spain, Top Therapy Area by Deal Number, 2018-2019
Figure 47: Medical Device Market Deals, Spain, M&A Deals by Therapy Area, 2018-2019
Figure 48: Medical Device Market Deals, Spain, Venture Financing Deals by Therapy Area, 2018-2019
Figure 49: Medical Device Market Deals, Spain, Private Equity Deals by Therapy Area, 2018-2019
Figure 50: Organization of the Health System, Spain, 2018

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Austerity measures implemented by the Spanish government have negated the effect of key drivers behind the country’s pharmaceutical market, resulting in a contracting market between 2008 and 2020, says research and consulting firm The authors.

However, the company’s latest report* states that factors, such as an aging population and free healthcare service, will help drive an overall expansion of the country’s healthcare market over the next six years.

According to The authors, Spain’s medical devices space was worth approximately $7.1 billion in 2008 and increased to around $8.5 billion in 2013, at a Compound Annual Growth Rate (CAGR) of 3.4%. It is expected to reach $12 billion by 2020, representing a CAGR of 5%.

The in vitro diagnostics and diabetic care device segments were the largest contributors to Spain’s medical device market in 2013. Other major segments included orthopedic, cardiovascular and ophthalmic devices.

Joshua Owide, The authors’s Director of Healthcare Industry Dynamics, says: “Spain’s medical devices sector is benefiting significantly from the increase in electronic health services and a strong MedTech industry. However, new drug pricing policies and the promotion of generics as a cost-containment tool are severely limiting the country’s pharmaceutical market growth.

“The government’s new policies, introduced in 2011 and 2012, require drug manufacturers to price their products lower than the reference price, and it is now mandatory for pharmacists to dispense the cheapest available drugs to patients, further impacting pharmaceutical market value.”

The authors states that due to these strict regulations to contain costs by 2020, the Association Européenne des Spécialités Pharmaceutiques Grand Public (AESGP) reported a decline in Spain’s pharmaceutical market revenues, from $29 billion in 2008 to $24 billion in 2013, at a negative CAGR of 3.7%.

The market’s value is expected to decrease even further to $22.6 billion by the end of the forecast period, representing a negative CAGR of 0.9%.

*CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Spain

This report provides information on the healthcare, regulatory, and reimbursement landscape in Spain. It includes an overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers, as well as an evaluation of the opportunities for and challenges to growth.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by The authors’s team of industry experts.
Note: Product cover images may vary from those shown
Adroll
adroll